INNOVADERM CRO IS NOW INDERO.

Patient-Centric Approaches to Managing Rheumatoid Arthritis Trials

patient centricity in rheumatoid arthritis clinical trials

Managing rheumatoid arthritis (RA) trials presents unique challenges and opportunities. RA patients often face significant pain and mobility issues, which can impact their participation in clinical studies. Effective management of these trials requires a comprehensive approach that addresses patient comfort, transportation, recruitment, retention, and site accessibility. Additionally, meticulous study management, including drug positioning, monitoring, and […]

Enhancing Rheumatoid Arthritis Patient Retention

Maintaining patient participation is a critical factor that can determine the success or failure of a study, particularly in the context of rheumatoid arthritis (RA) clinical trials. Excellent patient retention is a hallmark of quality sites that prioritize patient care and cultivate enduring relationships, leading to enhanced patient loyalty. Effective strategies, such as periodic surveys […]

Rheumatoid Arthritis: The Imperative of Patient Recruitment and Research Opportunities

The Rising Tide of Rheumatoid Arthritis and the Unmet Need Rheumatoid Arthritis (RA) is a severe autoimmune disease with profound physical, emotional, and socioeconomic impacts. Despite the introduction of targeted biological and pharmacological treatments, a significant number of RA patients still suffer from unbearable side effects. The rising prevalence of RA underscores the urgent need […]

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.